Compare DYN & MRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.
Marex Group PLC is a company that offers a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. It provides critical services to the clients by connecting them to global exchanges and providing a range of execution and hedging services across a range of its asset and products. They operate in a large and fragmented market with significant infrastructure requirements and regulatory and technological complexity, resulting in high barriers to entry.